The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors
- PMID: 35532818
- PMCID: PMC9520630
- DOI: 10.1007/s00018-022-04321-2
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors
Abstract
NSD1, NSD2, and NSD3 constitute the nuclear receptor-binding SET Domain (NSD) family of histone 3 lysine 36 (H3K36) methyltransferases. These structurally similar enzymes mono- and di-methylate H3K36, which contribute to the maintenance of chromatin integrity and regulate the expression of genes that control cell division, apoptosis, DNA repair, and epithelial-mesenchymal transition (EMT). Aberrant expression or mutation of members of the NSD family is associated with developmental defects and the occurrence of some types of cancer. In this review, we discuss the effect of alterations in NSDs on cancer patient's prognosis and response to treatment. We summarize the current understanding of the biological functions of NSD proteins, focusing on their activities and the role in the formation and progression in solid tumors biology, as well as how it depends on tumor etiologies. This review also discusses ongoing efforts to develop NSD inhibitors as a promising new class of cancer therapeutic agents.
Keywords: Cancer; H3K36 methyltransferases; Histone methylation; NSD1/KMT3B; NSD2/MMSET/WHSC1; NSD3/WHSC1L1; Solid tumors.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
The author declares he has no conflict of interest.
Figures





References
Publication types
MeSH terms
Substances
Grants and funding
- Translational Bridge Award/Feinberg School of Medicine
- P50 DE030707/DE/NIDCR NIH HHS/United States
- W81XWH2110487/U.S. Army Medical Research Acquisition Activity
- R01 CA218802/CA/NCI NIH HHS/United States
- 1P50 DE030707-01/NH/NIH HHS/United States
- P30 CA060553/CA/NCI NIH HHS/United States
- W81XWH-17-1-0578/U.S. Department of Defense
- W81XWH-17-1-0405/U.S. Department of Defense
- R01 CA218802/NH/NIH HHS/United States
- R01 DE027809/DE/NIDCR NIH HHS/United States
- P30 CA006927/CA/NCI NIH HHS/United States
- 2017CHAL2008/Prostate Cancer Foundation
- R01CA227918/NH/NIH HHS/United States
- R01 CA227918/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases